Aeterna Zentaris presents two posters on perifosine at AACR meeting Aeterna Zentaris Inc.
Aeterna Zentaris presents two posters on perifosine at AACR meeting Aeterna Zentaris Inc silagra reviews . Poster #1965: Entitled, Antitumor activity of novel Akt inhibitor, perifosine in gastric cell lines ,Tae Soo Kim, Hyo Tune Kim, Bo Ram Kwan, Chan Hee Recreation area, Hei-Cheul Jeung, Woo Ick Jang, Juergen Engel, Hyun Cheol Chung, Jae Kyung Roh, Sun Small Rha, . Outcomes Perifosine showed solitary agent anti-proliferative activity in a number of gastric cancers cell lines. In 8/13 cell lines resistant to 5-FU, perifosine demonstrated a synergistic antiproliferative activity with 5-FU. In 72 percent of cell lines, high basal degrees of pAkt were detected. Treatment with perifosine reduced tumor growth in nude mice inoculated with the YCC 2 gastric cancer cell range subcutaneously.
Both are high-risk and rarely performed. An alternative treatment option that is approved in Europe is now being tested in a scientific trial in the United States. Called the AeriSeal System, produced by Aeris Therapeutics, it uses a specialized foam sealant to seal and shrink diseased regions of the lung. That is thought to be a less risky method to reduce lung volume without main surgery. Reducing lung volume leaves more space for healthier parts of the lung to operate more effectively, making it simpler to breathe. It's believed this might improve standard of living for those living with more advanced emphysema. The ASPIRE Clinical Study calls for 300 patients at medical centers in the U approximately.S., Europe and Israel..